Hamill John P. Insider Trades

Insider Trading History

Track insider trading activity for Hamill John P.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $25.6k 30,978 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$47.3k 61,956 shares
$0.76
$0.83
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $36k 43,528 shares
Last Trade
Mar 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.6k 50,475 shares
$0.76
$0.83
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $27.7k 33,433 shares
Last Trade
Jan 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.46k 11,400 shares
$0.83
$0.83
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $23k 27,733 shares
Last Trade
Dec 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.41k 10,000 shares
$0.94
$0.83
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $18.8k 22,733 shares
Last Trade
Mar 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.6k 13,460 shares
$2.20
$0.83
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $16k 19,368 shares
Last Trade
Oct 11, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$123 50 shares
$2.46
$0.83
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $16k 19,318 shares
Last Trade
Oct 10, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.17k 450 shares
$2.61
$0.83
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $15.6k 18,868 shares
Last Trade
Mar 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90k 13,460 shares
$6.69
$0.83
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $12.8k 15,503 shares
Last Trade
Mar 13, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.61k 1,010 shares
$5.55
$0.83
Aprea Therapeutics
Aprea Therapeutics APRE
Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $12k 14,493 shares
Last Trade
Feb 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.25k 1,000 shares
$5.25
$0.83
Windtree Therapeutics
Windtree Therapeutics WINT
SVP & CFO
Holding Value $1.16k 72,800 shares
Last Trade
Jul 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.98M 3,000 shares
$992.25
$0.02
Windtree Therapeutics
Windtree Therapeutics WINT
SVP & CFO
Holding Value $1.59k 99,600 shares
Last Trade
Mar 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$274M 99,600 shares
$2,754.00
$0.02
Windtree Therapeutics
Windtree Therapeutics WINT
SVP & CFO
Holding Value $56 3,500 shares
Last Trade
Apr 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.78M 1,000 shares
$5,778.00
$0.02
Windtree Therapeutics
Windtree Therapeutics WINT
SVP & CFO
Holding Value $40 2,500 shares
Last Trade
Mar 25, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$18.9M 3,000 shares
$6,291.00
$0.02
Windtree Therapeutics
Windtree Therapeutics WINT
SVP & CFO
Holding Value $960 60,000 shares
Last Trade
Jan 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$881M 60,000 shares
$14,688.00
$0.02
Windtree Therapeutics
Windtree Therapeutics WINT
SVP & CFO
Holding Value $16 1,000 shares
Last Trade
Oct 07, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.2M 1,000 shares
$14,229.00
$0.02
Windtree Therapeutics
Windtree Therapeutics WINT
SVP & CFO
Holding Value $3.38k 211,000 shares
Last Trade
Jul 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.98B 211,000 shares
$18,846.00
$0.02
Trevena
Trevena TRVN
VP Fin,princ Fin&acct Officer
Holding Value $913 82,234 shares
Last Trade
Jun 03, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.03M 5,516 shares
$731.25
$0.01
Trevena
Trevena TRVN
VP Fin,princ Fin&acct Officer
Holding Value $974 87,750 shares
Last Trade
May 31, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.44M 7,500 shares
$725.00
$0.01
Trevena
Trevena TRVN
VP Fin,princ Fin&acct Officer
Holding Value $891 80,250 shares
Last Trade
Dec 06, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.5M 80,000 shares
$406.25
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up